Congresses
View the latest scientific data presented at congress events in the past 2 years by therapeutic area.
The material below is provided to support scientific exchange and pertains to select congress resources. It is not intended to serve as a comprehensive list of all congress events.
Any content about investigational therapeutics or investigational uses of locally approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of local regulatory approval.
The provision of this content is not intended to recommend or suggest use of its products in any manner inconsistent with local regulatory approval. For questions beyond a product’s authorized indications or for information not available here, please contact Alnylam Medical Information.
Transthyretin Amyloidosis (ATTR)
American Academy of Neurology (AAN) 2026
Cardiovascular (CV)
American College of Cardiology (ACC) 2026
Transthyretin Amyloidosis (ATTR)
American College of Cardiology (ACC) 2026
Acute Hepatic Porphyria (AHP)
Thrombosis and Hemostasis Summit of North America (THSNA) 2026
Neurologic
International Stroke Conference (ISC) 2026
Cardiovascular (CV)
Global Cardiovascular Clinical Trialists Forum (CVCT) 2025
Transthyretin Amyloidosis (ATTR)
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Europe 2025
Acute Hepatic Porphyria (AHP)
American Association for the Study of Liver Diseases (AASLD) 2025
Transthyretin Amyloidosis (ATTR)
American Heart Association (AHA) 2025
Cardiovascular (CV)
American Heart Association (AHA) 2025
Primary Hyperoxaluria Type 1 (PH1)
